Koninklijke Philips | PHG - Equity Capital And Reserves


Koninklijke Philips reported EUR12.87B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Boston Scientific USD 24.23B 1.58B Dec/2025
Danaher USD 52.95B 415M Mar/2026
Demant DKK 9.84B 446M Dec/2025
Dexcom USD 2.75B 19.9M Dec/2025
Edwards Lifesciences USD 10.34B 132.6M Dec/2025
Fresenius EUR 18.62B 320M Sep/2025
General Electric Aerospace USD 18.06B 841M Mar/2026
Getinge SEK 33.01B 2.75B Dec/2024
Globus Medical USD 4.57B 174.42M Dec/2025
GN Store Nord DKK 14.88B 4.33B Dec/2025
Hitachi JPY 6.57T 211.91B Mar/2026
Idexx Laboratories USD 1.61B 44.2M Dec/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 5.89M Dec/2025
Intuitive Surgical USD 17.47B 349.5M Mar/2026
J&J USD 81.19B 358M Mar/2026
Koninklijke Philips EUR 12.87B 489.5M Dec/2025
Masimo USD 721.2M 88.8M Dec/2025
Medtronic USD 48.99B 128M Dec/2025
Philips EUR 10.58B 204M Sep/2025
ResMed USD 6.32B 199.61M Dec/2025
Smith & Nephew USD 5.54B 331M Dec/2025
Steris USD 7.15B 145.4M Dec/2025
Stryker USD 21.78B 594M Sep/2025
Teleflex USD 3.12B 697.09M Dec/2025
Terumo JPY 1.52T 84.79B Dec/2025
Zimmer Biomet Holdings USD 12.7B 68.3M Dec/2025